Increased risk of thrombo-embolic events in patients with anti-phopholipid syndrome (APS) treated with Eliquis

Increased risk of thrombo-embolic events in patients with anti-phopholipid syndrome (APS) treated with Eliquis

2019 Sep

Download latest version
Document Number: DHCPL
Version: 1
Date Updated: 13/09/2019
File Type: pdf
Category: Communication To Health Care Professionals
Unit: Pharmacovigilance